Addpharma Inc.
50
8
8
29
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 50 trials
100.0%
+13.5% vs industry average
24%
12 trials in Phase 3/4
0%
0 of 29 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (50)
Determining the Optimal Dose of AD-211 in Patients With Osteoarthritis of the Knee
Role: lead
A Study to Evaluate the Safety and Pharmacokinetics of AD-123 Compared to Coadministration of AD-1231 and AD-1232
Role: lead
A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults
Role: lead
A Study to Evaluate the Effect of Food on the Pharmacokinetic Characteristics and Safety Profile of AD-117 in Healthy Adult Volunteers
Role: lead
A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 in Healthy Adult Subjects
Role: lead
A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects
Role: lead
A Clinical Trial to Assess the Pharmacokinetics and Safety of AD-229 Compared to AD-2291 in Healthy Adults
Role: lead
Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'
Role: lead
Evaluate the Pharmacokinetic Interaction and the Safety of AD-2321 and AD-2322
Role: lead
A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-231A and AD-231B and AD-231C
Role: lead
A Study to Compare to PK Characteristics and Safety Profiles Between AD-117 and AD-117A
Role: lead
A Study to Compare to PK Characteristics and Safety Profiles Between AD-227 and Co-administration of AD-227A and AD-227B
Role: lead
The Study Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'
Role: lead
A Clinical Trial to Evaluate the Safety and the Pharmacokinetics of AD-116 Compared to AD-1161 in Healthy Adult Male Volunteers
Role: lead
A Study to Evaluate the Safety and Pharmacokinetics of AD-228A Compared to Coadministration of AD-2281 and AD-2282
Role: lead
The Food Effect on PK Characteristics and Safety Profiles of PA-111
Role: lead
A Study to Compare to PK Characteristics and Safety Profiles Between PA-111 and PA-111A
Role: lead
A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-120 and AD-120A
Role: lead
A Study to Evaluate the Efficacy and Safety of AD-223
Role: lead
A Study to Compare PK Characteristics and Safety Profiles Between AD-228B and AD-2284
Role: lead